DEPO MEDROKSI PROGESTERON ASETAT (DMPA) INCREASES BODY MASS INDEX OF ACCEPTORS BUT DECREASES THEIR LIBIDO. Proceedings of the International Conference on Applied Science and Health, [S. l.], n. 2, p. 81–85, 2017. Disponível em: https://publications.inschool.id/index.php/icash/article/view/880.. Acesso em: 7 nov. 2024.